THYMUS REMOVAL RISKS

-
Hi Folks!! Follow our blog on Instagram LAB IN THE BOX

THYMUS REMOVAL RISKS



Removing the thymus in adults raises their risk of developing or dying of cancer in comparison with the risk for adults who do not undergo thymus removal according to a study published in The New England Journal of Medicine by researchers from Harvard University in Boston, Massachusetts. The study also shows that thymectomy in adults who have not had a prior infection, cancer diagnosis, or autoimmune disease diagnosis may also place them at higher risk of developing an autoimmune disease.
1420 patients who had undergone thymectomy and 6021 controls were included in the study; 1146 of the patients who had undergone thymectomy had a matched control and were included in the primary cohort. At 5 years after surgery, all-cause mortality was higher in the thymectomy group than in the control group (8.1% vs. 2.8%; relative risk, 2.9; 95% confidence interval [CI], 1.7 to 4.8), as was the risk of cancer (7.4% vs. 3.7%; relative risk, 2.0; 95% CI, 1.3 to 3.2). Although the risk of autoimmune disease did not differ substantially between the groups in the overall primary cohort (relative risk, 1.1; 95% CI, 0.8 to 1.4), a difference was found when patients with preoperative infection, cancer, or autoimmune disease were excluded from the analysis (12.3% vs. 7.9%; relative risk, 1.5; 95% CI, 1.02 to 2.2). In an analysis involving all patients with more than 5 years of follow-up (with or without a matched control), all-cause mortality was higher in the thymectomy group than in the general U.S. population (9.0% vs. 5.2%), as was mortality due to cancer (2.3% vs. 1.5%). In the subgroup of patients in whom T-cell production and plasma cytokine levels were measured (22 in the thymectomy group and 19 in the control group; mean follow-up, 14.2 postoperative years), those who had undergone thymectomy had less new production of CD4+ and CD8+ lymphocytes than controls (mean CD4+ signal joint T-cell receptor excision circle [sjTREC] count, 1451 vs. 526 per microgram of DNA [P = 0.009]; mean CD8+ sjTREC count, 1466 vs. 447 per microgram of DNA [P<0.001]) and higher levels of proinflammatory cytokines in the blood. Prior studies had shown that the adult thymus continues to produce T lymphocytes, under both pathologic and physiologic conditions, and this study supports an important role of that function.

Comments

Post a Comment

Popular posts from this blog

China's First ever CRISPR Cas9 system Patent!

-
Image
Hi Folks!! Follow our blog on  Instagram China’s patent and trademark office has upheld a key patent within the portfolio of CRISPR/Cas9 intellectual property belonging to Nobel Laureate Emmanuelle Charpentier, The Regents of the University of California, and University of Vienna (known collectively as CVC), and licensed for commercial use through ERS Genomics. Dublin-based ERS Genomics said the China National Intellectual Property Administration (CNIPA) has upheld Patent No. CN201380038920.6, “Methods and Compositions for RNA-guided Target DNA Modification and for RNA-guided Transcription Regulation”. ToolGen claims that it was the  world’s first  filer of patents covering gene editing in eukaryotic cells using the CRISPR-Cas9 system. “The decision by the CNIPA fully upholding the patent further demonstrates its validity and value as part of the patent collection for use of the CRISPR/Cas9 technology,” ERS Genomics stated in announcing the Chinese decision recently. The CVC patents ha
Read more

XPOSAT - STUDY ABOUT BLACKHOLE(A GIST)

-
Image
Hi Folks!! Follow our blog on Instagram  LAB IN THE BOX XPOSAT - STUDY ABOUT BLACKHOLE (A GIST) Last year was a huge success with Chandrayaan-3. Our ISRO Scientist did a lot of unexpected acts and surprised us all. On January 1st, when this year started, India has proved to be a leading country in the world, not only on land, but also in the sky.  There are a lot of things in our universe that we don't understand. One thing that we don't understand is black holes. These black holes exist in a lot of places in space. From the fact that we are in a black hole, to the fact that all the earth and sun will disappear one day in a black hole, this is something that we don't understand. From the biggest scientist to the modern technology scientist, everyone is looking at this black hole as a mystery. To study this, India has launched a special Mission on January 1st named XPoSat( X-ray Polarimeter Satellite). On January 1st, India launched 10 different satellites throug
Read more

History of Biotechnology

-
Image
HISTORY OF BIOTECHNOLOGY: People have been harnessing biological processes to improve their quality of life for some 10,000 years, beginning with the first agricultural communities. Approximately 6,000 years ago, humans began to tap the biological processes of microorganisms in order to make bread, alcoholic beverages, and cheese and to preserve dairy products. But such processes are not what is meant today by biotechnology, a term first widely applied to the molecular and cellular technologies that began to emerge in the 1960s and ’70s. A fledgling “biotech” industry began to coalesce in the mid- to late 1970s, led by Genentech, a pharmaceutical company established in 1976 by Robert A. Swanson and Herbert W. Boyer to commercialize the recombinant DNA technology pioneered by Boyer, Paul Berg, and Stanley N. Cohen. Early companies such as Genentech, Amgen, Biogen, Cetus, and Genex began by manufacturing genetically engineered substances primarily for medical and environmental uses. For
Read more